Peninsula biotech turns down $125M payout — gasp! — as it pushes on with late-stage eye drug trials

The move signaled the relative ease for some biotech companies seeking cash in a capital-intensive business as well as this company's progress in a handful of clinical trials.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news